A Study of Semagacestat for Alzheimer's Patients

NCT01035138 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: semagacestat

Sponsor

Eli Lilly and Company